CAC”). The Company intends to begin cultivation operations in the newly approved space later this month.
“We are pleased to announce the regulatory approval of the second phase of the planned expansion of our 117,000 sq ft cultivation and manufacturing facility in Taunton, Massachusetts,” said
Gary Santo, president of TILT. “We now have more than 56,000 sq. ft. of cultivation space with the ability to add a second grow tier to each of the eight new rooms, pending regulatory approval. Once planted, these additional rooms will fortify the supply of premium flower for our Taunton dispensary, and together with our award-winning kitchen and state-of-the art extraction and processing lab, will support the production and distribution of high-quality, consistent products for our brand partners. As we continue to solidify CAC’s presence in the state, we remain committed to working with the CCC to achieve final state licenses permitting medical dispensary operations at our Brockto
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
TILT Holdings Inc. Receives Approval for Additional Cultivation Expansion at its Massachusetts .
TILT Holdings Inc.March 2, 2021 GMT
Combination of Phase One and Phase Two Expansion More
Than Doubles Company’s Cultivation Capacity in Commonwealth
Company’s Expanded Facility Supports B2B Brand Strategy While
Addressing Massachusetts’ Growing Marketplace Demands
PHOENIX, March 02, 2021 (GLOBE NEWSWIRE) TILT Holdings Inc. (“TILT” or the “Company”) ( CSE: TILT ) ( OTCQX: TLLTF ), a provider of business solutions to the global cannabis industry that includes inhalation technologies, cultivation, manufacturing, processing, brand development, distribution and retail, announced it received regulatory approval from the Massachusetts Cannabis Control Commission (“CCC”) to commence operation of eight additional grow rooms at its subsidiary, Commonwealth Alternative Care